Share on Facebook
Share on Twitter
Share on LinkedIn

Actavis ($ACT) has another drug recall to deal with, this one involving nearly 65,000 bottles of the generic version of the seizure drug Neurontin that it manufactures at a plant in India. The voluntary recall follows one in November of a drug that was key to its acquisition last year of Forest Pharmaceuticals.

The drugmaker is voluntarily recalling different doses of gabapentin after it got complaints that capsules were clumping and breaking and that some bottles from one distribution center had popped-out or rounded bottoms and creased labels. The company said the drugs were manufactured at a plant in Tamil Nadu, India.

Read More.